Does 'Strong Analgesic' Equal 'Strong Opioid'? Tapentadol and the Concept of 'µ-Load'

about

Does 'Strong Analgesic' Equal 'Strong Opioid'? Tapentadol and the Concept of 'µ-Load'

Item

http://www.wikidata.org/entity/Q58749196

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Does 'Strong Analgesic' Equal 'Strong Opioid'? Tapentadol and the Concept of 'µ-Load'

@en

Does 'Strong Analgesic' Equal 'Strong Opioid'? Tapentadol and the Concept of 'µ-Load'

@nl

type

Item

label

Does 'Strong Analgesic' Equal 'Strong Opioid'? Tapentadol and the Concept of 'µ-Load'

@en

Does 'Strong Analgesic' Equal 'Strong Opioid'? Tapentadol and the Concept of 'µ-Load'

@nl

prefLabel

Does 'Strong Analgesic' Equal 'Strong Opioid'? Tapentadol and the Concept of 'µ-Load'

@en

Does 'Strong Analgesic' Equal 'Strong Opioid'? Tapentadol and the Concept of 'µ-Load'

@nl

P1476

Does 'Strong Analgesic' Equal 'Strong Opioid'? Tapentadol and the Concept of 'µ-Load'

@en

P2093

Christian Elling

http://www.w3.org/2001/XMLSchema#string

Robert B Raffa

http://www.w3.org/2001/XMLSchema#string

Thomas M Tzschentke

http://www.w3.org/2001/XMLSchema#string

P2860

Buprenorphine: a unique drug with complex pharmacology

Computational methods in drug discovery

Mechanistic and functional differentiation of tapentadol and tramadol

On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data

Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs.

Central modulation of pain.

Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain.

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.

P2888

s12325-018-0778-x

P304

1471-1484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S12325-018-0778-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30206823

http://www.w3.org/2001/XMLSchema#string

P921

opioid

P932

6182641

http://www.w3.org/2001/XMLSchema#string